Linked-in Link Twitter Link

Prof Steve Howell Joins the Board of Innova Biosciences

Feb 01, 2016

Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, today announced the appointment of Professor Steve Howell to the Board of Directors.

Steve, CEO of Innova Partnerships, commented; “Innova Biosciences’ world leading bioconjugation technology business is backed by a team of dedicated executives, scientists and customer service personnel. I am very pleased to be joining the Board, to help lead Innova through its next stages of development.”

Read full article on Innova Biosciences Website